Dubai Health today announced the launch of ‘The Child Fund’ by Al Jalila Foundation, in the presence of His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors. The pioneering annual charitable fund amounting to AED50 million will be dedicated to providing essential medical treatment for 3,000 children every year at Al Jalila Children’s Hospital, the UAE’s first and only dedicated children’s hospital.

The announcement was made at Al Jalila Children’s Hospital in the presence of Her Excellency Dr. Raja Easa Saleh Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member; His Excellency Dr. Amer Sharif, CEO of Dubai Health and President of the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dr. Amer Al Zarooni, Chief Executive Officer of Al Jalila Foundation, Dr. Abdulla Al Khayat, Chief Executive Officer of Al Jalila Children’s Hospital, in addition to a number of officials and major donors.

During his tour of Al Jalila Children’s Hospital, HH Sheikh Mansoor visited a group of young patients and was briefed on the hospital’s specialty services that underscore its commitment to prioritising child-friendly healthcare focused on quality and excellence.

His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoumconveyed his gratitude to all donors and contributors who play a pivotal role in upholding the highest standards of excellence within the health system in Dubai. Their collective efforts contribute significantly to providing the best forms of healthcare, particularly for children. This commitment aligns with the enduring values of giving and compassion that have consistently defined the people of the UAE and its society, His Highness said.

Sheikh Mansoor said: “The launch of 'The Child Fund' underscores our steadfast dedication to ensuring comprehensive care for children, which is a paramount focus within Dubai's health system. We consider it our fundamental responsibility to uphold the highest standards of care for them, as they symbolise the foundation of our future. Through such community initiatives, our goal is to extend support and deliver treatment to the largest number of children, with the ultimate aim of enabling them to lead normal lives.”

‘The Child Fund’ will serve as a dedicated children’s charity programme designed to raise funds for providing essential, life-saving medical support to children in need. Beyond being a beacon of hope for children and their families in the UAE, the initiative aims to cultivate a culture of giving within the community, ensuring that every child receives the care they need to thrive.

Her Excellency Dr. Raja Al Gurghighlighted Al Jalila Foundation’s role in supporting Dubai Health’s philanthropic mission. She said: “For over a decade, Al Jalila Foundation has made a significant impact through its A’awen patient treatment programme, touching the lives of thousands of patients and their families across the UAE. With this new fund, we pledge to extend the reach of our care and provide renewed hope for a brighter and more promising tomorrow for even more children. ‘The Child Fund’ reaffirms our heartfelt commitment to securing a healthy future for our children. Today, we proudly recognise the unwavering dedication and generosity of our donors and supporters who, together, united by care and compassion, are lighting the path to healing young lives.”

Dr. Abdulla Al Khayat, said:“’The Child Fund’ goes beyond just providing essential medical treatment for children in need, it is a beacon of hope for families and their loved ones facing life-threatening illnesses. Through this initiative our dedicated team of doctors and physicians can extend life-saving care to those who cannot afford access to necessary treatments.”

“We are eternally grateful for the opportunities ‘The Child Fund’ will provide to our doctors and physicians, aligning with Al Jalila Children's unwavering dedication to excellence in treating young patients. The Fund, reflecting our ‘Patient First’ promise, will enable us to extend care to children of all ages, empowering them to step into a more promising tomorrow," said Dr. Al Khayat.

'The Giving Wall'

During the launch, 'The Giving Wall' was unveiled as a tribute to the donors and contributors that have impacted children’s lives through their support to Al Jalila Foundation. They were invited to sign a pledge in support of the AED50 million annual fund dedicated to providing essential medical care for 3,000 children per year. Notable partners include the Mohammed Bin Rashid Al Maktoum Humanitarian & Charity Establishment; Easa Saleh Al Gurg Charity Foundation; Islamic Affairs & Charitable Activities Department; Awqaf Dubai; Albatha Holding; IFFCO; and Tarahum.

‘The Child Fund’ builds on Al Jalila Foundation’s impactful history of philanthropic achievements in supporting a number of healthcare programmes in medical education, research and patient care transforming thousands of lives. The Foundation has supported medical treatment to over 8,600 patients, including 30% children, suffering from life-threatening conditions including cancer, cardiovascular disease and other chronic illnesses, underscoring its ongoing commitment to transforming lives of those in need in the community.

Click the link ‘The Child Fund’ for more information.  

A delegation from UMass Chan Medical School, Massachusetts’s first and only public academic health sciences center, recently visited Dubai Health, solidifying a new chapter in healthcare collaboration between the two organizations. The visit, marked by the signing of a Memorandum of Understanding (MOU), granted the delegation the opportunity to gain insight into Dubai’s first integrated academic health system, laying the groundwork for a productive partnership.

Inspired by UMass Chan’s reputation for impact through collaborative endeavour and aspiration to change the course of the history of disease, the partnership reflects a shared vision between the two academic health systems to advance health. Under the agreement, UMass Chan and Dubai Health will establish mutually beneficial research projects to improve patient care, create an exchange framework for learners between the two academic institutions, and drive transformative advancements for public health, both locally and globally.

Led by Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor at UMass Chan, the visit also included an opportunity for Dubai Health learners to gain insight into elective and residency program opportunities at UMass Chan.

Commenting on the partnership, Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, stated, “This collaboration presents an exciting opportunity to combine the strengths of two academic health organizations. By pooling our resources, capabilities, and expertise, we are well-positioned to advance the frontier of medical knowledge that better serves our communities. The visit has been incredibly productive, laying the foundation for meaningful collaboration anchored in our shared purpose of advancing health for humanity.”

Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor of UMass Chan commented “It is a privilege, along with a group of senior colleagues, to learn more about the breadth and depth of activity taking place at Dubai Health and to forge closer relationships with its leadership. The signing of an MOU between our respective institutions is an exciting development and provides UMass Chan and Dubai Health with a framework from which to pursue meaningful collaborations and exchanges, by partnering, we do hope to advance together on behalf of the communities that we serve.”

The UMass Chan delegation included Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor; Terence R. Flotte, MD, Provost, Dean, and Executive Deputy Chancellor; David D. McManus, MD, Chair, Department of Medicine; Anne Larkin, MD, Associate Professor of Surgery, Vice Provost, and Senior Associate Dean for Educational Affairs; Lisa Colombo, DNP, MHA, RN, Executive Vice Chancellor and CEO, ForHealth Consulting; Rebekah Diamond, JD, Executive Director, Business Strategy & Operational Excellence, ForHealth Consulting; Brendan Chisholm, Vice Chancellor of Management, Chief of Staff, Office of the Chancellor.

Dubai Health, the first integrated academic health system in Dubai, has partnered with the Angelman Syndrome Foundation to establish the GCC’s first dedicated clinic at Al Jalila Children’s Hospital. This is the first-of-its-kind clinic in the region and aims to improve care for patients with Angelman Syndrome and raise awareness of this rare neurological disorder. The clinic will provide a supportive community hub where patients, families and caregivers can connect with experts and receive the best evidence-based care, bridging a gap in healthcare for those living with this condition.  

In line with Dubai Health’s Patient First promise, the partnership with the Angelman Syndrome Foundation represents new hope for individuals and families living with this rare neuro-genetic disorder. Affecting approximately one in 500,000 people worldwide, the early symptoms of Angelman Syndrome include a significant delay in obtaining developmental milestones such as walking within the first 12 months. Other clinical findings include speech delay, movement or balance disorder and often present with an apparent happy demeanor with frequent laughter and excitability.

The clinic will provide families in the UAE access to specialist healthcare professionals and evidence-based care while also enhancing future treatment through the power of Dubai Health’s integrated academic health system. Through harnessing the education and research that takes place within Dubai Health, this partnership aims to significantly improve the lives of patients and their families.

Dr. Abdulla Al Khayat, CEO of Al Jalila Children’s Hospital, said: “We are delighted to partner with The Angelman Syndrome Foundation to bring this specialized clinic to Al Jalila Children’s Hospital, part of Dubai Health care network. This crucial partnership is a beacon of hope for patients and families affected by this rare condition. By ensuring that we deliver the highest standard of care and driven by our Patient First promise, we hope to empower Angelman Syndrome patients and their families to lead fulfilling lives.”

Also commenting on the partnership, Amanda Moore, CEO of the Angelman Syndrome Foundation, said: "We are deeply honored to join forces with Dubai Health and Al Jalila Children's Hospital in this transformative initiative. This clinic will offer families in the UAE access to professionals with deep knowledge of Angelman Syndrome, expertise that has traditionally been challenging to locate. Raising awareness of rare conditions like Angelman Syndrome is crucial for early diagnosis and better patient outcomes. This initiative is part of our LADDER Learning Network, designed to bridge critical gaps in the healthcare landscape for families dealing with this rare disorder. We look forward to working closely with the team at Dubai Health to making a significant difference to the lives of patients and their families.”